Suppression of virulence factors of uropathogenic Escherichia coli by Trans-resveratrol and design of nanoemulgel
BMC Microbiology · 2024
DOI: 10.1186/s12866-024-03538-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift BMC Microbiology, 2024. Verfasst von Dalia Saad ElFeky und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Microbiology and Immunology, Faculty of Medicine, Cairo University, Cairo, Egypt. dselfeky@cu.edu.eg. Hauptthemen laut MEDLINE: Uropathogenic Escherichia coli, Virulence Factors, Resveratrol, Biofilms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cairo University.
Abstract (Originalsprache)
Background
Development of multidrug resistance in Uropathogenic Escherichia coli (UPEC) makes treatment of Urinary Tract Infections (UTIs) a major challenge. This study was conducted to investigate the effect of trans-resveratrol (t-RSV) at a subinhibitory concentration (sub-MIC-t-RSV) on phenotypic and genotypic expression of virulence factors of clinical isolates of UPEC and develop a nanoformulation of t-RSV. Fifty-five clinical UPEC strains were investigated for the presence of virulence factors by phenotypic methods and PCR detection of virulence genes. The effect of sub-MIC-t-RSV was studied on the phenotypic and genotypic expression of virulence factors. t-RSV-loaded nanoemulgel formulation was prepared and characterized.
Results
Out of the 55 tested isolates, 50.9% were biofilm producers, 23.6% showed both mannose-sensitive and mannose-resistant hemagglutination, 21.8% were serum-resistant, 18.2% were hemolysin producers, while 36.4% showed cytotoxic effect on HEp-2 cells. A total of 25.5% of the isolates harbor one or more of hly-A , cnf-1 and papC genes, while 54.5% were positive for one or more of fimH , iss and BssS genes . A concentration of 100 µg/mL of t-RSV effectively downregulates the phenotypic and genotypic expression of the virulence factors in positive isolates. A stable t-RSV-nanaoemulgel with droplet size of 180.3 nm and Zetapotential of -46.9 mV was obtained.
Conclusion
The study proves the effective role of t-RSV as an antivirulence agent against clinical UPEC isolates in vitro and develops a stable t-RSV-nanoemulgel formulation to be assessed in vivo. The promising antibacterial and antivirulence properties of t-RSV place this natural compound to be a better alternative in the treatment of persistent UTIs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Microbiology and Immunology, Faculty of Medicine, Cairo University, Cairo, Egypt. dselfeky@cu.edu.eg.
- Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Pharos University in Alexandria, Alexandria, Egypt.
- Health Sciences Research center, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.
- Department of Microbiology and Immunology, Faculty of Pharmacy, Mansoura University, Mansoura, 35516, Egypt.
Förderung
- Cairo University
Zitieren
APA
ElFeky, D. S., Kassem, A. A., Moustafa, M. A., Assiri, H., & El-Mahdy, A. M. (2024). Suppression of virulence factors of uropathogenic Escherichia coli by Trans-resveratrol and design of nanoemulgel. BMC Microbiology. https://doi.org/10.1186/s12866-024-03538-4
Vancouver
ElFeky DS, Kassem AA, Moustafa MA, Assiri H, El-Mahdy AM. Suppression of virulence factors of uropathogenic Escherichia coli by Trans-resveratrol and design of nanoemulgel. BMC Microbiology. 2024. doi:10.1186/s12866-024-03538-4
BibTeX
@article{ElFeky2024,
author = {ElFeky, Dalia Saad and Kassem, Abeer Ahmed and Moustafa, Mona A and Assiri, Hanan and El-Mahdy, Areej M},
title = {Suppression of virulence factors of uropathogenic Escherichia coli by Trans-resveratrol and design of nanoemulgel},
journal = {BMC Microbiology},
year = {2024},
doi = {10.1186/s12866-024-03538-4}
}
EUVIMED